What's known on the subject? and What does the study add? Very few comparative studies
to date evaluate the results of treatment options for prostate cancer using the most sensitive …

Abstract Brachytherapy (BT), using low-dose-rate (LDR) permanent seed implantation or
high-dose-rate (HDR) temporary source implantation, is an acceptable treatment option for …

PURPOSE: To provide updated American Brachytherapy Society (ABS) guidelines for
transrectal ultrasound-guided transperineal interstitial permanent prostate brachytherapy …

PURPOSE: We provide current information on the use of PSA testing for the evaluation of
men at risk for prostate cancer, and the risks and benefits of early detection. MATERIALS …

Context In the United States, 192 000 men were diagnosed as having prostate cancer in
2009, the majority with low-risk, clinically localized disease. Treatment of these cancers is …

PURPOSE: To investigate the value of dose–volume histogram (DVH) parameters for
predicting local control in magnetic resonance (MR) image-guided brachytherapy (IGBT) for …

Among men who experience prostate‐specific antigen (PSA) failure after external beam
radiation or brachytherapy (RT), many will harbor occult micrometastases; however, a …

Abstract The first ESMO Consensus Conference on prostate cancer was held in Zurich,
Switzerland, on 17–19 November 2011, with the participation of a multidisciplinary panel of …

OBJECTIVE: To evaluate the long-term efficacy of high-intensity focused ultrasound (HIFU)
therapy for patients with localised prostate cancer. MATERIAL AND METHODS: Patients …

PURPOSE: To report the clinical outcome of high-dose-rate (HDR) interstitial (IRT)
brachytherapy (BRT) as sole treatment (monotherapy) for clinically localized prostate …